Bioinformatics Job Market Report: Q2 2026

Biotech hiring overall stayed cautious through the first half of 2026, as the sector works through the aftermath of the 2024–2025 funding contraction and its wave of layoffs. Computational roles held up better than most: bioinformatics, biostatistics, and data-science skills remain among the harder-to-fill categories in drug discovery and development, and our board reflects that resilience.

One note on how to read this report. We tracked 631 positions from 128 companies in Q2, up from 419 in Q1 — but a large share of that increase is us widening our own coverage (we began tracking many more employers this quarter), not the market suddenly expanding by half. So the numbers to trust are the compositional ones — who's hiring, for which roles, at what pay, and where — which hold regardless of how many postings we catch. Those are what we dig into below.

"Biostatistics overtook machine learning as the most common role type in bioinformatics hiring this quarter — even as ML roles took three of the five top-paying spots on the board." — CompBioJobs Q2 2026 Job Market Report

Who's Hiring: A Broad Pharma Field, Not One Dominant Employer

Genentech was again the largest single employer in our Q2 data with 48 roles (43 of them full-time), down from Q1's 78 as summer intern season ended. But the top of the market this quarter is broad rather than concentrated: Gilead (31), AstraZeneca (30), Dana-Farber Cancer Institute (29), Bristol Myers Squibb (27), Novartis (26), Merck (25), Pfizer (24) and Amgen (24) all cluster right behind it. Flagship Pioneering's portfolio (24) rounds out the top 10, with Natera (23) just outside. The headline: no single employer dominates Q2 — the leaderboard is a wide pharma field.

Highest-Paying Employers in Q2 2026

The AI Salary Premium: 8% of Jobs, the Top of the Pay Scale

Machine learning and AI roles make up just 8% of Q2 postings — but they hold the #1, #2 and #3 highest-paying spots on the board, and the single highest-paid role in the field is an ML/AI position. AI/ML pay is setting the ceiling and pulling the overall average up with it.

The premium reflects two separate markets operating under the same category label. AI startups (Lila Sciences, Flagship portfolio) pay tech-company rates — equity-heavy, wide bands, benchmarked against ML talent in general tech. Pharma ML teams (Genentech, Novartis) pay senior pharma science rates plus an AI uplift, typically 15–25% above a comparable wet-lab or stat role at the same level.

One thing the posted ranges hide: these aren't the same dollars. That $570K at a private, venture-backed Flagship spinout is heavily equity-weighted and illiquid — its real value rides on an exit that may never come. A $430K pharma range is cash-and-bonus dominant and largely guaranteed. And an academic-medical role near $180K trades cash for stability, publications, and clinical proximity. So when you weigh an AI-native offer against a pharma one, you're comparing expected-value-with-risk against near-certain cash — not two points on the same scale. Model your own range with our compensation calculator →

Where Bioinformatics Jobs Are: Boston Leads, New York Climbing

Boston/Cambridge remains the largest single hub at 26% of Q2 jobs, with the SF Bay Area at 18%, remote at 11%, and New York at 8%. The clearest pattern is geographic spread: nearly a third of Q2 roles sit outside the major named hubs. Some of that broadening is real (pharma sites in Maryland, San Diego, and abroad), and some is our wider coverage this quarter — so read the shares as a Q2 snapshot rather than a hub-by-hub trend line.

Most In-Demand Bioinformatics Roles: Biostatistics Overtakes Data Science

Biostatistics and statistical programming was the single largest role category we tracked in Q2 (80 postings), ahead of data science, computational biology, machine learning, and bioinformatics. Read this as a snapshot, not a swing: we improved how we detect statistician and statistical-programming titles this quarter, which lifts this category's count directly. The durable takeaway is the level — regulatory and late-stage statistical work, including CDISC-compliant SDTM/ADaM datasets for FDA submissions, is a large and often-underappreciated share of computational hiring, not just discovery-stage ML.

What to Learn: Skills Behind the Q2 Demand

Our data tracks roles, not resumes — but the recurring requirements in these postings point clearly at what to build.

Seniority: Q2 Is Full-Time Season

Intern postings collapsed from 65 in Q1 to just 5 in Q2 — the expected seasonal swing, since Q1 is intern-recruiting season. Beyond that, the Q2 mix skews senior: 156 Senior/Staff roles, 97 Director-level openings, and 91 Principal positions. Much of the computational hiring right now is for experienced individual contributors and leaders, not entry level.

Bioinformatics & Computational Biology Salaries: Floor Up 9%, Transparency Hits 69%

The average salary floor rose from $136K in Q1 to $148K in Q2 — a 9% jump. Read that with one caveat: it's partly compositional. Intern postings (which carry low or no salary and drag the floor down) collapsed from 65 to 5, while senior and Principal roles grew, so the mix of disclosed-salary roles skewed more senior this quarter — and that alone lifts the average floor. The honest read of "+9%" is "the market is disclosing pay on more senior roles," not necessarily "+9% for the same job"; we don't have per-level Q1 salary data to isolate true like-for-like wage growth. Transparency is the clearer trend: 69% of Q2 postings disclosed salary ranges, up from 56% in Q1, as more California and New York employers — and large pharma — post ranges proactively.

Salary by Experience Level

Average of posted salary ranges. Of 433 Q2 postings with a disclosed range (69% of all jobs), 10 sub-$50K postings (likely hourly/contract) are excluded, leaving n = 423.

Top 5 Highest-Paying Roles

What We're Watching Into Q3

What This Means For Your Search Right Now

Frequently Asked Questions

Methodology

This report analyzes jobs first tracked on CompBioJobs between April 1 and June 30, 2026. Jobs are classified as relevant to bioinformatics, computational biology, and related fields using LLM-based relevance scoring (threshold: 60/100). Salary data reflects posted ranges; actual compensation varies. Role categories use keyword matching and may overlap — a single job can appear in multiple categories. Seniority classification is based on title keywords. Geographic classification uses the primary location field; remote jobs are counted separately from their company's physical location. Company counts consolidate obvious name variants (e.g. "Gilead" / "Gilead Sciences"); our raw data tool, which counts each company string separately, returns 143 distinct employer names for Q2. Coverage caveat: CompBioJobs aggregates from company career pages and job boards, and our coverage expanded this quarter — so quarter-over-quarter totals (jobs and companies) reflect our tracking as much as the market, and are not a market-size measure. The compositional figures (pay, role mix, seniority, geography share) are far more robust. Q1 2026 figures are quoted from our published Q1 2026 report as a point-in-time snapshot; because expired postings are removed from the live database over time, prior-quarter counts cannot be reproduced by re-running our data tool today. See the Q1 2026 report for baseline comparison data.